BioWorld

March 14, 2003

View Archived Issues

Streptococcus Pneumoniae Will Thumb Nose At Top Antibiotics Penicillin, Erythromycin In 2004

Read More

Boston Life Sciences Raises $10M In Private Placement

Read More

With Shareholders In Mind, SignalGene To Close Doors

Read More

Correction

Read More

Other News To Note

Read More

Challenges Of Confirmatory Trials Subject Of FDA Panel

After a decade of clearing certain oncology drugs under accelerated approval guidelines, the FDA is asking companies to explain why it takes so long to successfully complete confirmatory efficacy studies. (BioWorld Today) Read More

Cytokine PharmaSciences Signs Baxter To MIF Technology Deal

Read More